Drug intelligence / Profile preview

Speromed

Development stage: Unknown
Lead developer: Huro Biotech
Administration: Intranasal

Overview

Speromed is a retail nasal spray developed and launched in Vietnam by HURO Biotech. It is based on the SPOR-COV technology, for which Destiny Pharma and SporeGen granted non-exclusive manufacturing rights and exclusive commercial rights to HURO Biotech in Vietnam. HURO Biotech also developed the GMP manufacturing process and conducted local clinical tolerability studies for Speromed.

Brand names: Speromed

Beyond the preview

Go deeper on Speromed.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Speromed.

Explore the full profile